NASA is offering Fitbit devices to 1,000 mission-critical employees, including 150 astronauts, to mitigate the risk of spreading infectious disease among astronaut flight crews in the immediate preflight period.
The Mountain View, CA-based company won clearance from FDA for an expanded range of ECG determinations and had research with Mayo Clinic published in the peer-reviewed journal Circulation.
The OPRA Implant System has been on the market under a humanitarian device exemption since 2015 and is now fully approved by FDA for patients who have trouble with conventional socket prosthetics.
The Marlborough, MA-based company has signed a multi-year agreement to integrate Google Cloud’s machine learning technologies with the Genius Digital System for the screening of cervical cancer.
Moray Medical is developing a interventional robotics platform powered by microfluidics and an augmented reality digital user interface. The company's initial focus is on the transcatheter mitral valve repair market.
The Chicago, IL-based company has acquired a contact-free continuous monitoring technology from EarlySense for $30 million with the potential for milestones.
The Valencia, CA-based company has raised $64 million in a preferred stock financing. SetPoint Medical said the financing will help move its pivotal trial for the development of its bioelectronic platform to treat rheumatoid arthritis.